Retinal homogenates were prepared using RIPA buffer (Millipore) containing protease and phosphatase inhibitors (Complete Mini and phosSTOP, respectively; Roche Applied Science, Indianapolis, IN). Proteins were separated on SDS-PAGE and transferred onto nitrocellulose membranes (Millipore), blocked in 5% milk or 3% BSA in TBST (Tris-buffered saline with 0.5% Tween-20). The membrane was incubated overnight (4°C) in primary antibodies diluted in blocking solution consisting of NOX2 (1:500; Abcam, Cambridge, MA), NF-κB p65 (1:1000; Cell Signaling Technology), p-P65 (Ser536, 1:1000, Cell Signaling Technology), ERK (1:5000; Cell Signaling Technology), p-ERK (Thr202/Tyr 204, 1:5000; Cell Signaling Technology), c-jun N-terminal kinase (JNK; 1:1000; Cell Signaling Technology), p-JNK (Thr183/Tyr185, 1:1000; Cell Signaling Technology), p38 MAPK (1:1000; Cell Signaling Technology), p-p38 MAPK (Thr180/Tyr182, 1:1000; Cell Signaling Technology), GFAP (1:1000; Sigma-Aldrich), and tubulin (1:10,000; Sigma-Aldrich). The next day, the membrane was washed in TBST, followed by horseradish peroxidase-conjugated secondary antibody (1:10,000 for tubulin, 1:5000 for ERK and p-ERK, 1:2000 for the other antibodies). Immunoreactive proteins were detected using the enhanced chemiluminescence system (GE Healthcare Bio-Science Corp., Piscataway, NJ).